Current role
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
2026-01-01–present
Charles Gayer
Board Member
Biocryst Pharmaceuticals Inc (BCRX)Equibles does not estimate personal net worth.
Get an email with a short summary when Biocryst Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get BCRX alertsAbout Charles Gayer
Charles Gayer is recorded as Board Member at Biocryst Pharmaceuticals Inc (BCRX) since January 1, 2026 and CEO at Biocryst Pharmaceuticals Inc (BCRX). The newest filing on record that lists Charles Gayer as CEO and Board Member at Biocryst Pharmaceuticals Inc (BCRX) is dated April 23, 2026. The proxy statement of Biocryst Pharmaceuticals Inc reports total compensation of $9,627,868 for Charles Gayer in fiscal 2025, including a base salary of $609,397. Disclosed compensation is on record for 4 fiscal years. Biocryst Pharmaceuticals Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Biocryst Pharmaceuticals Inc includes Charlie Gayer (CEO and Board Member), Vincent J. Milano (Chairman and Board Member), Babar Ghias (CFO and Chief Accounting Officer) and 7 others.
Affiliation history
-
Current
2026-01-01–present
Last confirmed April 23, 2026
-
Current
Start not stated–present
Last confirmed April 23, 2026
-
Biocryst Pharmaceuticals Inc (BCRX)
Proxy statement
Start not stated–2025-04-24
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Biocryst Pharmaceuticals Inc
- Charlie Gayer CEO, Board Member
- Vincent J. Milano Chairman, Board Member
- Babar Ghias CFO, Chief Accounting Officer
- Jon P. Stonehouse CFO, Chief Accounting Officer, Board Member
- Thomas R. Staab II CFO
- A. Machelle Sanders Board Member
- Alan G. Levin Board Member
- Amy E. McKee Board Member
- Amy E. McKee, M.D. Board Member
- Amy McKee, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Biocryst Pharmaceuticals Inc (BCRX) | President and Chief Executive Officer; Former Chief Commercial Officer | $609,397 | $9,627,868 |
| 2024 | Biocryst Pharmaceuticals Inc (BCRX) | Chief Commercial Officer | $544,830 | $3,375,210 |
| 2023 | Biocryst Pharmaceuticals Inc (BCRX) | Chief Commercial Officer | $495,300 | $1,738,544 |
| 2022 | Biocryst Pharmaceuticals Inc (BCRX) | Chief Commercial Officer | $448,700 | $2,198,862 |
Recent activity
No call appearances or filed executive changes recorded yet.